1. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial. Issue 10 (October 2020) Authors: DiNardo, Courtney D; Maiti, Abhishek; Rausch, Caitlin R; Pemmaraju, Naveen; Naqvi, Kiran; Daver, Naval G; Kadia, Tapan M; Borthakur, Gautam; Ohanian, Maro; Alvarado, Yesid; Issa, Ghayas C; Montalban-Bravo, Guillermo; Short, Nicholas J; Yilmaz, Musa; Bose, Prithviraj; Jabbour, Elias J; Takahashi, ... Journal: Lancet Issue: Volume 7:Issue 10(2020) Page Start: e724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 10-day vs 5-day decitabine: equivalence cannot be concluded – Authors' reply. Issue 4 (April 2019) Authors: Short, Nicholas J; Ravandi, Farhad Journal: Lancet Issue: Volume 6:Issue 4(2019) Page Start: e178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Acute myeloid leukaemia. Issue 10147 (18th August 2018) Authors: Short, Nicholas J; Rytting, Michael E; Cortes, Jorge E Journal: Lancet Issue: Volume 392:Issue 10147(2018) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemia. Issue 7 (July 2022) Authors: Short, Nicholas J; Kantarjian, Hagop Journal: Lancet Issue: Volume 9:Issue 7(2022) Page Start: e535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study. Issue 12 (December 2018) Authors: Jabbour, Elias; Short, Nicholas J; Ravandi, Farhad; Huang, Xuelin; Daver, Naval; DiNardo, Courtney D; Konopleva, Marina; Pemmaraju, Naveen; Wierda, William; Garcia-Manero, Guillermo; Sasaki, Koji; Cortes, Jorge; Garris, Rebecca; Khoury, Joseph D; Jorgensen, Jeffrey; Jain, Nitin; Alvarez, Joie; O'... Journal: Lancet Issue: Volume 5:Issue 12(2018) Page Start: e618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Harnessing the benefits of available targeted therapies in acute myeloid leukaemia. Issue 12 (December 2021) Authors: Kantarjian, Hagop; Short, Nicholas J; DiNardo, Courtney; Stein, Eytan M; Daver, Naval; Perl, Alexander E; Wang, Eunice S; Wei, Andrew; Tallman, Martin Journal: Lancet Issue: Volume 8:Issue 12(2021) Page Start: e922 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial. Issue 12 (December 2022) Authors: Jabbour, Elias; Short, Nicholas J; Jain, Nitin; Thompson, Philip A; Kadia, Tapan M; Ferrajoli, Alessandra; Huang, Xuelin; Yilmaz, Musa; Alvarado, Yesid; Patel, Keyur P; Garcia-Manero, Guillermo; Macaron, Walid; Garris, Rebecca; Konopleva, Marina; Ravandi, Farhad; Kantarjian, Hagop Journal: Lancet Issue: Volume 9:Issue 12(2022) Page Start: e878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial. Issue 7 (July 2020) Authors: Jabbour, Elias; Richard-Carpentier, Guillaume; Sasaki, Yuya; Konopleva, Marina; Patel, Keyur; Roberts, Kathryn; Gu, Zhaohui; Wang, Feng; Huang, Xuelin; Sasaki, Koji; Short, Nicholas J; Jain, Nitin; Ravandi, Farhad; Daver, Naval G; Kadia, Tapan M; Alvarado, Yesid; DiNardo, Courtney D; Issa, Ghayas... Journal: Lancet Issue: Volume 7:Issue 7(2020) Page Start: e523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study. Issue 2 (February 2018) Authors: Kantarjian, Hagop; Ravandi, Farhad; Short, Nicholas J; Huang, Xuelin; Jain, Nitin; Sasaki, Koji; Daver, Naval; Pemmaraju, Naveen; Khoury, Joseph D; Jorgensen, Jeffrey; Alvarado, Yesid; Konopleva, Marina; Garcia-Manero, Guillermo; Kadia, Tapan; Yilmaz, Musa; Bortakhur, Gautam; Burger, Jan; Kornbla... Journal: Lancet oncology Issue: Volume 19:Issue 2(2018) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial. Issue 1 (January 2023) Authors: Jabbour, Elias; Short, Nicholas J; Jain, Nitin; Huang, Xuelin; Montalban-Bravo, Guillermo; Banerjee, Pinaki; Rezvani, Katayoun; Jiang, Xianli; Kim, Kun Hee; Kanagal-Shamanna, Rashmi; Khoury, Joseph D; Patel, Keyur; Kadia, Tapan M; Daver, Naval; Chien, Kelly; Alvarado, Yesid; Garcia-Manero, Guille... Journal: Lancet Issue: Volume 10:Issue 1(2023) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗